Advanced Haematology Analyzer Launched by ErbaTransasia Group in Karnataka

ErbaTransasia Group launches Erba H7100 Haematology Analyzer in Karnataka, revolutionizing diagnostic accuracy with cutting-edge technology.

Jan 27, 2025 - 14:05
 0  21
Advanced Haematology Analyzer Launched by ErbaTransasia Group in Karnataka
Advanced Haematology Analyzer Launched by ErbaTransasia Group in Karnataka

Bengaluru: ErbaTransasia Group, India’s leading In-vitro Diagnostic (IVD) company, unveiled the Erba H7100 Haematology Analyzer during a clinical symposium in Bengaluru. The event, themed "Need for High-End Haematology Analyzers to Tackle Current Challenges Faced by Clinical Laboratories," featured insights from notable experts, including Dr. Anil Handoo of BLK-Max Super Speciality Hospital, Delhi.

The Erba H7100 offers breakthrough features, such as fluorescence flow cytometry technology and a 70-parameter range, aiding in diagnosing conditions like anemia, blood cancers, infections, and hereditary disorders. The system also integrates advanced functionalities, including Reticulocytes and Immature Platelet Fraction (IPF) analysis, to enhance diagnostic accuracy.

Addressing Karnataka's rising cancer burden, experts emphasized the importance of advanced diagnostic tools like the Erba H7100. Dr. Handoo noted, "This analyzer bridges diagnostic gaps for underserved communities, particularly those dealing with genetic disorders like thalassemia."

Key highlights of the Erba H7100 include its ability to perform 90 tests per hour and a feature-rich interface that improves efficiency for medium to large-scale labs. Vijay Kumar, CCO and Country Head of Transasia Bio-Medicals Ltd explained, "The analyzer differentiates between conditions like Iron Deficiency Anaemia and Beta Thalassemia, making it a game-changer for laboratories."

The symposium also focused on integrating reticulocyte parameters for better disease management. This technology supports customized treatment strategies, enhances therapy monitoring, and streamlines laboratory workflows. The Erba H7100 empowers healthcare professionals to provide superior patient care by addressing challenges like pseudo-thrombocytopenia and improving platelet count accuracy.

Suresh Vazirani, Founder Chairman of ErbaTransasia Group, remarked, "With innovative capabilities and cost-effectiveness, the Erba H7100 sets a new benchmark in haematology diagnostics." The launch signifies a transformative step toward advancing healthcare technology in India.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow